140
Participants
Start Date
December 7, 2018
Primary Completion Date
October 19, 2019
Study Completion Date
December 31, 2019
Immunotherapy
Patients with primitive head and neck squamous cells carcinoma diagnosed on surgical resection or biopsic sample, between 2008 and 2015. They were included when expressing p16 as assessed by immunochemistry and positive HPV DNA by in situ hybridation or positive HPV PCR
Hôpital Européen Georges Pompidou, Paris
CHU Martinique, Fort-de-France
European Georges Pompidou Hospital
OTHER
University Hospital Center of Martinique
OTHER